NEW

GE HealthCare Preps for SIR 2024

GE HealthCare will showcase its latest technologies in image guiding solutions, surgery, ultrasound and CT-navigation at the upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting taking place March 23-28 in Salt Lake City, Utah. The...

Samsung Accepts Healthcare Innovator Award

Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business, was awarded HHM Health’s Healthcare Innovator Award

AHRA Co-Founder Passes Away

On March 2, 2024, Louise Broadley passed away at 101 years old. AHRA shared the news via an email and website post that reads, “She was a noble woman, who not only achieved many milestones within the imaging profession, but likewise paved the way for aspiring leaders...

Artificial Intelligence Paper Outlines FDA’s Approach to Protect Public Health and Promote Ethical Innovation

Today, the U.S. Food and Drug Administration (FDA) released its “Artificial Intelligence and Medical Products: How CBER, CDER, CDRH, and OCP are Working Together,” which outlines how FDA’s medical product centers are working together to protect public health while...

MITA: Copyright Office Recommendation Would Undermine Medical Device Safety and Put Patients at Risk

The Medical Imaging & Technology Alliance (MITA)

The Medical Imaging & Technology Alliance (MITA) – the leading trade association representing manufacturers of medical imaging equipment, radiopharmaceuticals, contrast media, and focused ultrasound therapeutic devices – said today that the U.S. Copyright Office recommendation to allow unregulated Independent Service Organizations (ISOs) to access and copy the technology that operates medical imaging devices would create unnecessary safety and security risks for patients.

In comments submitted to the Copyright Office, MITA explained that, while original equipment manufacturers (OEMs) are regulated by the Food and Drug Administration (FDA), ISOs are not subject to the same quality control, training and reporting requirements. Having disparate levels of FDA regulation, training and quality control increases patient risk and the threat of cyberattacks on hospitals. Allowing ISOs to legally hack into imaging systems raises these risks exponentially.

“If this recommendation is ultimately accepted and implemented, it would amount to a license for unregulated third-party servicers to hack sensitive technology, creating grievous cybersecurity and patient safety risks,” said Patrick Hope, Executive Director, MITA. “Current intellectual property protections for OEMs do not prevent ISOs from servicing equipment, and in fact, OEMs can service other manufacturers’ equipment without hacking into it. This recommendation would increase the risk of harm for patients and healthcare providers since third-party servicers are not regulated by the FDA. We intend to continue to advocate against this misguided approach.”

MITA further pointed out that disabling of TPMs would expose intellectual property, including valuable know-how in addition to the copyrighted information, to competitors and the general public. That itself would severely harm OEMs by allowing competitors to view and replicate valuable innovations.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

Open